Group 2A carcinogen
-
Acrylamide-reducing yeast technology gains industry interest
Functional Technologies said it has made considerable progress towards the commercialization of its patent-pending acrylamide-reducing (AR) yeast technology. Acrylamide is a known Group 2A carcinogen (cancer-causing agent), and is formed in starch…
Group 2A carcinogen | 09 November 2010
